Utility of the pp65 direct antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipients.
Sharma
A K
AK
Transplant Unit, Royal Liverpool University Hospital, UK.
Taylor
J D
JD
Tong
W
W
Brown
M W
MW
Sells
R A
RA
Bakran
A
A
D000956:Antigens, Viral / Q000097:blood*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002102:Cadaver; D016009:Chi-Square Distribution; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D019520:Living Donors; D009504:Neutrophils / Q000821:virology; D010750:Phosphoproteins / Q000097:blood*; D011183:Postoperative Complications; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014019:Tissue Donors; D014763:Viral Matrix Proteins / Q000097:blood*
D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa